Status:

COMPLETED

The Effect of Nurse Practitioner Led-Care on Quality of Life in Patients With Atrial Fibrillation

Lead Sponsor:

University of Alberta

Collaborating Sponsors:

University Hospital Foundation

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Atrial fibrillation (AF) is the most common heart rhythm disease characterized by an irregular heart rhythm of the top part (atria) of the heart. It may cause unpleasant symptoms as well as increases ...

Eligibility Criteria

Inclusion

  • 18 years or older
  • Documented non valvular atrial fibrillation
  • Able to provide informed consent
  • Able and willing to complete the study questionnaires on own or with assistance

Exclusion

  • Referral is for atrioventricular node ablation or pulmonary vein isolation.
  • Patients who have failed antiarrhythmic medications
  • Patients with moderate to severe mitral or aortic valvular heart disease
  • Clinically unstable atrial fibrillation
  • Cannot or unwilling to attend follow-up appointments

Key Trial Info

Start Date :

July 31 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 30 2020

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT02745236

Start Date

July 31 2016

End Date

November 30 2020

Last Update

April 28 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mazankowski Alberta Heart Institution

Edmonton, Alberta, Canada, T6G 2B7